论文信息 - Serotonin: A New Hope in Alzheimer's Disease?

Serotonin: A New Hope in Alzheimer's Disease?

Alzheimer's disease (AD) is the most common form of dementia affecting 35 million individuals worldwide. Current AD treatments provide only brief symptomatic relief. It is therefore urgent to replace this symptomatic approach with a curative one. Increasing serotonin signaling as well as developing molecules that enhance serotonin concentration in the synaptic cleft have been debated as possible therapeutic strategies to slow the progression of AD. In this Viewpoint, we discuss exciting new insights regarding the modulation of serotonin signaling for AD prevention and therapy.

[1] E. Marchetti-Gauthier,et al. Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer’s disease , 2013, Front. Aging Neurosci..

[2] Yvette I. Sheline,et al. An Antidepressant Decreases CSF Aβ Production in Healthy Individuals and in Transgenic AD Mice , 2014, Science Translational Medicine.

[3] K. Blennow,et al. Comment on “An antidepressant decreases CSF Aβ production in healthy individuals and in transgenic AD mice” , 2014, Science Translational Medicine.

[4] Kristian Windfeld,et al. Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial , 2014, The Lancet Neurology.

[5] S. Corvaisier,et al. Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment , 2014, Proceedings of the National Academy of Sciences.

[6] J. Cirrito,et al. Genetic Modulation of Soluble Aβ Rescues Cognitive and Synaptic Impairment in a Mouse Model of Alzheimer's Disease , 2014, The Journal of Neuroscience.

[7] M. Mintun,et al. Serotonin signaling is associated with lower amyloid-β levels and plaques in transgenic mice and humans , 2011, Proceedings of the National Academy of Sciences.